UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 721

Sortiert nach

Race and sex associations with tacrolimus pharmacokinetics in stable kidney transplant recipients

Pharmacotherapy, 2022-02, Vol.42 (2), p.94-105

2022

Volltextzugriff (PDF)

Multidrug resistant 1 (MDR1) C3435T and G2677T gene polymorphism: impact on the risk of acute rejection in pediatric kidney transplant recipients

Italian journal of pediatrics, 2023-05, Vol.49 (1), p.57-57, Article 57

2023

Volltextzugriff (PDF)

The effect of ABCB1 C3435T polymorphism on pharmacokinetics of tacrolimus in liver transplantation: A meta-analysis

Gene, 2013-12, Vol.531 (2), p.476-488

2013

Volltextzugriff (PDF)

Meta-analysis of the effect of MDR1 C3435 polymorphism on tacrolimus pharmacokinetics in renal transplant recipients

Transplant immunology, 2012-08, Vol.27 (1), p.12-18

2012

Volltextzugriff (PDF)

The associations of IL-18 serum levels and promoter polymorphism with tacrolimus pharmacokinetics and hepatic allograft dysfunction in Chinese liver transplantation recipients

Gene, 2012-01, Vol.491 (2), p.251-255

2012

Volltextzugriff (PDF)

Pharmacokinetics for Once‐ Versus Twice‐Daily Tacrolimus Formulations in De Novo Kidney Transplantation: A Randomized, Open‐Label Trial

American journal of transplantation, 2009-11, Vol.9 (11), p.2505-2513

2009

Volltextzugriff (PDF)

Clinical determinants of calcineurin inhibitor disposition: a mechanistic review

Drug metabolism reviews, 2016-01, Vol.48 (1), p.88-112

2016

Volltextzugriff (PDF)

High tacrolimus trough level variability is associated with rejections after heart transplant

American journal of transplantation, 2018-10, Vol.18 (10), p.2571-2578

2018

Volltextzugriff (PDF)

Time-dependent variability in tacrolimus trough blood levels is a risk factor for late kidney transplant failure

Kidney international, 2014-06, Vol.85 (6), p.1404-1411

2014

Volltextzugriff (PDF)

Pharmacogenetic aspects of the use of tacrolimus in renal transplantation: recent developments and ethnic considerations

Expert opinion on drug metabolism & toxicology, 2016-05, Vol.12 (5), p.555-565

2016

Volltextzugriff (PDF)

Interpreting tacrolimus concentrations during pregnancy and postpartum

Transplantation, 2013-04, Vol.95 (7), p.908

2013

Volltextzugriff (PDF)

External evaluation of published population pharmacokinetic models of tacrolimus in adult renal transplant recipients

British journal of clinical pharmacology, 2016-05, Vol.81 (5), p.891-907

2016

Volltextzugriff (PDF)

Role of FK506 Binding Protein on Tacrolimus Distribution in Red Blood Cells

Pharmaceutical research, 2020-07, Vol.37 (7), p.143, Article 143

2020

Volltextzugriff (PDF)

Genotype‐Guided Model for Prediction of Tacrolimus Initial Dosing After Lung Transplantation

Journal of clinical pharmacology, 2024-06, Vol.64 (6), p.719-727

2024

Volltextzugriff (PDF)

The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients

European journal of clinical pharmacology, 2014-06, Vol.70 (6), p.685-693

2014

Volltextzugriff (PDF)

Application of machine learning to predict tacrolimus exposure in liver and kidney transplant patients given the MeltDose formulation

European journal of clinical pharmacology, 2023-02, Vol.79 (2), p.311-319

2023

Volltextzugriff (PDF)

A Population Pharmacokinetic Model to Predict the Individual Starting Dose of Tacrolimus Following Pediatric Renal Transplantation

Clinical pharmacokinetics, 2018-04, Vol.57 (4), p.475-489

2018

Volltextzugriff (PDF)

A population pharmacokinetic model to predict the individual starting dose of tacrolimus in adult renal transplant recipients

British journal of clinical pharmacology, 2019-03, Vol.85 (3), p.601-615

2019

Volltextzugriff (PDF)

Pharmacokinetics and Safety of Letermovir Coadministered With Cyclosporine A or Tacrolimus in Healthy Subjects

Clinical pharmacology in drug development, 2018-01, Vol.7 (1), p.9-21

2018

Volltextzugriff (PDF)

Progressive decline in tacrolimus clearance after renal transplantation is partially explained by decreasing CYP3A4 activity and increasing haematocrit

British journal of clinical pharmacology, 2015-09, Vol.80 (3), p.548-559

2015

Volltextzugriff (PDF)

Pharmacokinetics of Tacrolimus in Pregnant Solid‐Organ Transplant Recipients: A Retrospective Study

Journal of clinical pharmacology, 2024-04, Vol.64 (4), p.428-436

2024

Volltextzugriff (PDF)

Predictors of tacrolimus pharmacokinetic variability: current evidences and future perspectives

Expert opinion on drug metabolism & toxicology, 2020-09, Vol.16 (9), p.769-782

2020

Volltextzugriff (PDF)

A New Functional CYP3A4 Intron 6 Polymorphism Significantly Affects Tacrolimus Pharmacokinetics in Kidney Transplant Recipients

Clinical chemistry (Baltimore, Md.), 2011-11, Vol.57 (11), p.1574-1583

2011

Volltextzugriff (PDF)

Modelling changes in the pharmacokinetics of tacrolimus during pregnancy after kidney transplantation: A retrospective cohort study

British journal of clinical pharmacology, 2024-01, Vol.90 (1), p.176-188

2024

Volltextzugriff (PDF)

Tacrolimus Variability and Clinical Outcomes in the Early Post-lung Transplantation Period: Oral Versus Continuous Intravenous Administration

Clinical pharmacokinetics, 2024-05, Vol.63 (5), p.683-693

2024

Volltextzugriff (PDF)

1 – 25 von 721

Suche als RSS-Feed

Aktive Filter

ThemaPharmacokinetics

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(691)
Mit Volltextzugriff
(562)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(642)
Life Sciences & Biomedicine
(625)
Tacrolimus
(598)
Humans
(464)
Pharmacology & Pharmacy
(365)
Male
(328)
Immunosuppressive Agents - Pharmacokinetics
(313)
Tacrolimus - Pharmacokinetics
(309)
Female
(296)
Kidney Transplantation
(260)
Adult
(259)
Transplantation
(234)
Middle Aged
(227)
Tacrolimus - Administration & Dosage
(205)
Immunosuppressive Agents - Administration & Dosage
(194)
Drug Dosages
(156)
Biological And Medical Sciences
(153)
Medical Sciences
(153)
Transplants & Implants
(140)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Race and sex associations with tacrolimus pharmacokinetics in stable kidney transplant recipients

Multidrug resistant 1 (MDR1) C3435T and G2677T gene polymorphism: impact on the risk of acute rejection in pediatric kidney transplant recipients

The effect of ABCB1 C3435T polymorphism on pharmacokinetics of tacrolimus in liver transplantation: A meta-analysis

Meta-analysis of the effect of MDR1 C3435 polymorphism on tacrolimus pharmacokinetics in renal transplant recipients

The associations of IL-18 serum levels and promoter polymorphism with tacrolimus pharmacokinetics and hepatic allograft dysfunction in Chinese liver transplantation recipients

Pharmacokinetics for Once‐ Versus Twice‐Daily Tacrolimus Formulations in De Novo Kidney Transplantation: A Randomized, Open‐Label Trial

Clinical determinants of calcineurin inhibitor disposition: a mechanistic review

High tacrolimus trough level variability is associated with rejections after heart transplant

Time-dependent variability in tacrolimus trough blood levels is a risk factor for late kidney transplant failure

Pharmacogenetic aspects of the use of tacrolimus in renal transplantation: recent developments and ethnic considerations

Interpreting tacrolimus concentrations during pregnancy and postpartum

External evaluation of published population pharmacokinetic models of tacrolimus in adult renal transplant recipients

Role of FK506 Binding Protein on Tacrolimus Distribution in Red Blood Cells

Genotype‐Guided Model for Prediction of Tacrolimus Initial Dosing After Lung Transplantation

The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients

Application of machine learning to predict tacrolimus exposure in liver and kidney transplant patients given the MeltDose formulation

A Population Pharmacokinetic Model to Predict the Individual Starting Dose of Tacrolimus Following Pediatric Renal Transplantation

A population pharmacokinetic model to predict the individual starting dose of tacrolimus in adult renal transplant recipients

Pharmacokinetics and Safety of Letermovir Coadministered With Cyclosporine A or Tacrolimus in Healthy Subjects

Progressive decline in tacrolimus clearance after renal transplantation is partially explained by decreasing CYP3A4 activity and increasing haematocrit

Pharmacokinetics of Tacrolimus in Pregnant Solid‐Organ Transplant Recipients: A Retrospective Study

Predictors of tacrolimus pharmacokinetic variability: current evidences and future perspectives

A New Functional CYP3A4 Intron 6 Polymorphism Significantly Affects Tacrolimus Pharmacokinetics in Kidney Transplant Recipients

Modelling changes in the pharmacokinetics of tacrolimus during pregnancy after kidney transplantation: A retrospective cohort study

Tacrolimus Variability and Clinical Outcomes in the Early Post-lung Transplantation Period: Oral Versus Continuous Intravenous Administration

Aktive Filter

Suchergebnisse filtern